Thus, although bvFTD and DAT show diagnostic differences in brain networks, the symptom of disinhibition, which occurs at least to some extent in both diagnoses, shares a common underlying neural substrate, that of decreased global efficiency of the CCN. Here, SLC6A3 is linked to behavioral variant of frontotemporal dementia.